MABWELL-B's stock soared 5.21% in intraday trading on Tuesday, marking a strong debut on the Hong Kong Stock Exchange.
The significant price surge comes as the stock opened at HK$28.3 per share, which is notably higher than its initial public offering price of HK$27.64. This premium opening reflects robust investor demand for the pharmaceutical company's shares.
The company's Hong Kong IPO generated substantial interest, with the public offer being oversubscribed by 481.71 times and the international offering attracting 3.46 times covered orders. Mabwell raised approximately HK$1.19 billion in net proceeds from the offering, with cornerstone investors including Junshi Hong Kong Limited and Sanjin International taking up a significant portion of the shares.
Comments